Progestin intrauterine device in an adolescent with grade 2 endometrial cancer
Brown, A.J.; Westin, S.N.; Broaddus, R.R.; Schmeler, K.
Obstetrics and Gynecology 119(2 Part 2): 423-426
2012
ISSN/ISBN: 1873-233X PMID: 22270425 DOI: 10.1097/aog.0b013e318234d97cDocument Number: 535216
The treatment of endometrial cancer in young women who desire future fertility poses several challenges. Oral progestin and progestin-releasing intrauterine devices (IUDs) have been shown to result in regression of endometrial hyperplasia and grade 1 endometrioid endometrial carcinoma. However, limited data are available on the use of these methods in women with grade 2 disease. An 18-year-old nulliparous woman was diagnosed with a grade 2 endometrial adenocarcinoma. She desired future fertility and therefore underwent placement of a levonorgestrel-releasing IUD. The patient subsequently underwent endometrial sampling every 3 months and remained disease-free 13 months after initial IUD placement. A progestin-releasing IUD may be a valid treatment option for grade 2 endometrial cancer in young women who desire to retain fertility.